Adherence Across the Life Span HIV Symposium
The Mid Atlantic AIDS Education Training Center (AETC) site at Johns Hopkins University will host the 6th Annual Adherence Across the Life Span HIV Symposium. This half-day workshop will address the unique issues of getting to viral suppression through Antiretroviral Therapy (ART) adherence in adolescents as well those aging up with HIV/AIDS. Experts in the field will provide current information pertaining to the timeline from treatment to viral suppression of HIV including barriers such as COVID, mental health, substance use disorder, and stigma. We will also cover patient advocacy and best practices, through informative interactive presentations. You must register both on maaetc.org and also Zoom Meeting to attend this event.
Brief event agenda:
9:00am - 9:10am ET: Registration and Welcome
9:15am - 10:00am: Session 1
10:00am - 10:45am: Session 2
10:45am - 11:00am: Break
11:00am - 11:30am: Session 3
11:30am - 12:15pm: Session 4
12:15pm - 12:45pm: Session 5
12:45pm - 1:00pm: Wrap up and evaluation
CME CEUs are available from the University of Nebraska for session 1 only.
CEUs for social workers, counselors, and therapists are provided by Johns Hopkins University for this event.
You must complete all required evaluations in order to be eligible to receive continuing education credit.
For more information, please contact Ingrid McDowell at firstname.lastname@example.org.
A variety of the listed populations will be discussed at this event.
- Young Adults (ages 18 to 24)
- Older Adults (ages 50 and over)
- Black or African American
- Gay, lesbian, bisexual, transgender, or other gender
MAAETC Adherence Flyer and Agend:
A variety of the listed topics will be discussed at this event.
- Harm Reduction/Safe Injection
- HIV Transmission Risk Assessment
- Pre-exposure prophylaxis (PrEP)
- Adult and adolescent antiretroviral treatment
- Aging and HIV
- Antiretroviral treatment adherence, including viral load suppression
- Hepatitis C
- Medication-assisted therapy for substance use disorders (i.e. buprenorphine, methadone, and/or naltrexone)
- Mental health disorders
- Motivational interviewing
- Stigma or discrimination
- Community linkages
- Health insurance coverage (i.e. Affordable Care Act, health insurance exchanges, managed care)
- Use of technology (i.e. electronic health records)